A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

LBL-024 for Injection

LBL-024 was given every three weeks for treatment

Trial Locations (49)

100005

RECRUITING

Peking Union Medical College Hospital, Beijing

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

100142

RECRUITING

Beijing Cancer Hospital, Beijing

110000

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

RECRUITING

The First Hospital of China Medical University, Shenyang

130000

RECRUITING

The First Hospital of Jilin University, Ch’ang-ch’un

150000

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

210000

RECRUITING

Jiangsu Cancer Hospital, Nanjing

RECRUITING

Nanjing First Hospital, Nanjing

210008

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

230000

RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

230002

RECRUITING

Anhui Provincial Hospital, Hefei

230601

RECRUITING

The Second Hospital of Anhui Medical University, Hefei

250000

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Shandong Cancer Hospital & Institute, Jinan

300181

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

310000

RECRUITING

Sir Run Run Shaw Hospital, Hangzhou

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

310003

RECRUITING

The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

310005

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

325015

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330000

NOT_YET_RECRUITING

The Second Affiliated Hospital Nanchang University, Nanchang

330006

RECRUITING

The Ferst Affiliated Hospital of Nanchang University, Nanchang

350000

RECRUITING

Fujian Cancer Hospital, Fuzhou

NOT_YET_RECRUITING

Fujian Medical University Union Hospital, Fuzhou

361000

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

400030

RECRUITING

Chongqing Cancer Hospital, Chongqing

410031

RECRUITING

Hunan Cancer Hospital, Changsha

430000

RECRUITING

Tongji Hospital, Wuhan

RECRUITING

Wuhan Union Hospital of China, Wuhan

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

441000

RECRUITING

Xiangyang Central Hospital, Xiangyang

450000

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

450052

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

455000

RECRUITING

Anyang Tumor Hospital, Anyang

471003

RECRUITING

The First Affilated Hospital of Henan University of Science & Technology, Luoyang

510000

RECRUITING

Sun Yat-sen University Cancer Center, Guanzhou

510062

RECRUITING

The First Affiliated Hospital,Sun Yat-sen University, Guangzhou

530000

RECRUITING

Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning

563000

RECRUITING

Affiliated Hospital of Zunyi Medical University, Zunyi

610000

RECRUITING

Sichuan Cancer Hospital, Chengdu

650000

RECRUITING

Yunnan Cancer Hospital, Kunming

710061

RECRUITING

The First Affiliated Hospital of Xi'An Jiaotong University, Xi’an

050011

RECRUITING

Fourth Hospital of Hebei Medical University, Shijiazhuang

Unknown

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

030000

NOT_YET_RECRUITING

Shanxi Bethune Hospital, Taiyuan

RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

Mianyang

NOT_YET_RECRUITING

Mianyang Central Hospital, Mianyang

All Listed Sponsors
lead

Nanjing Leads Biolabs Co.,Ltd

INDUSTRY